Skip to main content
SpringerLink
Log in

PCSK9 as a Therapeutic Target in Atherosclerosis

  • Clinical Trial Report
  • Published:
Current Atherosclerosis Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Lagace TA, Curtis DE, Garuti R, et al.:Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and in livers of parabiotic mice. J Clin Invest 2006, 116:2995–3005.

    Article  CAS  PubMed  Google Scholar 

  2. Abifadel M, Varret M, Rabes JP, et al.: Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat Genet 2003, 34:154–156.

    Article  CAS  PubMed  Google Scholar 

  3. Cohen J, Pertsemlidis A, Kotowski IK, et al.: Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9. Nat Genet 2005, 37:161–165.

    Article  CAS  PubMed  Google Scholar 

  4. Cohen JC, Boerwinkle E, Mosley TH Jr, Hobbs HH: Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med 2006, 354:1264–1272.

    Article  CAS  PubMed  Google Scholar 

  5. Chen SN, Ballantyne CM, Gotto AM Jr, et al.: A common PCSK9 haplotype, encompassing the E670G coding single nucleotide polymorphism, is a novel genetic marker for plasma low-density lipoprotein cholesterol levels and severity of coronary atherosclerosis. J Am Coll Cardiol 2005, 45:1611–1619.

    Article  CAS  PubMed  Google Scholar 

  6. Frank-Kamenetsky M, Grefhorst A, Anderson NN, et al.: Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates. Proc Natl Acad Sci U S A 2008, 105:11915–11920.

    Article  CAS  PubMed  Google Scholar 

  7. Ridker PM, Danielson E, Fonseca FA, et al.: Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Lancet 2009, 373:1175–1182.

    Article  CAS  PubMed  Google Scholar 

  8. Dubuc G, Chamberland A, Wassef H, et al.: Statins upregulate PCSK9, the gene encoding the proprotein convertase neural apoptosis-regulated convertase-1 implicated in familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 2004, 24:1454–1459.

    Article  CAS  PubMed  Google Scholar 

  9. Marian AJ: Nature’s genetic gradients and the clinical phenotype. Circ Cardiovasc Genet 2009, 2:537–539.

    Article  PubMed  Google Scholar 

  10. Zhao Z, Tuakli-Wosornu Y, Lagace TA, et al.: Molecular characterization of loss-of-function mutations in PCSK9 and identification of a compound heterozygote. Am J Hum Genet 2006, 79:514–523.

    Article  CAS  PubMed  Google Scholar 

  11. Graham MJ, Lemonidis KM, Whipple CP, et al.: Antisense inhibition of proprotein convertase subtilisin/kexin type 9 reduces serum LDL in hyperlipidemic mice. J Lipid Res 2007, 48:763–767.

    Article  CAS  PubMed  Google Scholar 

  12. Duff CJ, Scott MJ, Kirby IT, et al.: Antibody-mediated disruption of the interaction between PCSK9 and the low-density lipoprotein receptor. Biochem J 2009, 419:577–584.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Cardiovascular Genetics, The Brown Foundation Institute of Molecular Medicine, Texas Heart Institute at St. Luke’s Episcopal Hospital, The University of Texas Health Science Center at Houston, 6770 Bertner Street, DAC 900, Houston, TX, 77030, USA

    Ali J. Marian

Authors
  1. Ali J. Marian
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ali J. Marian.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Marian, A.J. PCSK9 as a Therapeutic Target in Atherosclerosis. Curr Atheroscler Rep 12, 151–154 (2010). https://doi.org/10.1007/s11883-010-0099-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11883-010-0099-2

Keywords

Search

Navigation